Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06326775
Research on Precision Pharmaceutical Care for Heart Transplant Recipients
Sponsor: Nanjing First Hospital, Nanjing Medical University
View on ClinicalTrials.gov
Summary
Establishing personalized dose prediction and related adverse drug reaction prediction models for immunosuppressive drugs after heart transplantation using multiple methods to construct a precise pharmaceutical service system for heart transplant patients has important research value and clinical significance in improving the safety and effectiveness of medication for patients.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2024-03-12
Completion Date
2026-12
Last Updated
2024-03-22
Healthy Volunteers
No
Conditions
Locations (1)
Pharmacy Department of Nanjing First Hospital
Nanjing, Jiangsu, China